Prof. Christian Steidlの率いるBC Cancerの悪性リンパ腫研究グループは、リンパ系がん患者の臨床転帰を向上させることを使命としています。
リンパ系がんはヒトで5番目に頻度の高いがんであり、あらゆる年齢の患者が罹患します。一般的には効果的な治療法が存在するにもかかわらず、依然として疾患の進行や再発により多くの患者が命を落としています。BC CancerのSteidl研究室では、独自に管理された患者コホートを活用し、次世代シークエンシング解析やイメージングマスサイトメトリー解析を行い、そこから得られた知見を検証する基礎実験を並行して行うことで、世界に先駆けてこの分野における先進的なエビデンスを提供してきました。
グローバルなコンソーシアム(Leukemia and Lymphoma Molecular Profiling Project、Interlymph Hodgkin lymphoma group)や臨床試験グループ(Eastern Clinical Oncology Group、Children’s Oncology Group、Canadian Cancer Trials Groupなど)の一員として、国際的な協力関係を築きつつ、Steidl研究室独自の悪性リンパ腫病態研究を展開しています。
Year |
Position |
Organization |
Location |
2002 – 2006 |
Physician Scientist |
University of Goettingen |
Germany |
2006 – 2011 |
Research Fellow |
British Columbia Cancer Agency |
Canada |
2011 – 2016 |
Scientist |
British Columbia Cancer Agency Research Centre |
Canada |
2011 – 2016 |
Assistant Professor |
University of British Columbia |
Canada |
2011 – Present |
Associate Faculty Member |
CIHR/MSFHR Bioinformatics Training Program |
Canada |
2012 – Present |
Associate Faculty Member |
Interdisciplinary Oncology Program |
Canada |
2014 – 2016 |
Deputy Department Head |
British Columbia Cancer Agency |
Canada |
2016 – 2020 |
Associate Professor |
University of British Columbia |
Canada |
2016 – 2020 |
Senior Scientist |
British Columbia Cancer Agency |
Canada |
2016 – Present |
Department Head |
British Columbia Cancer Agency |
Canada |
2018 – Present |
Associate Vice President Research |
British Columbia Cancer Agency |
Canada |
2020 – Present |
Professor |
University of British Columbia |
Canada |
2020 – Present |
Distinguished Scientist |
British Columbia Cancer Agency |
Canada |
2023 – Present |
Professor |
Institute of Medicine, University of Tsukuba |
Japan |
Year |
Membership |
Organization |
2004 – 2008 |
Member |
German-Austrian MDS study group |
2006 – Present |
Member |
American Society of Hematology (ASH) |
2008 – 2010 |
Member |
Cytogenetics Committee, International Working Group on Prognosis in Myelodysplasia |
2012 – Present |
Member |
Canadian Institutes of Health Research “Fellowships – Post-PhD” committee |
2013 – Present |
Scientific reviewer |
German Research Foundation (DFG) |
2013 – Present |
Reviewer |
Department of Pathology (UBC), Outstanding Academic Performance & Merit Committee |
2016 – Present |
Member |
Leukemia and Lymphoma Molecular Profiling Project (LLMPP) |
2017 – Present |
Co-Chair |
American Society of Hematology (ASH) Scientific Committee on Lymphoid Neoplasia |
2017 – Present |
Member |
Royal Society of Canada’s College of New Scholars, Artists and Scientists |
Year |
Honor |
Organization |
Location |
1995 – 2001 |
Foerderungsstipendium Scholarship |
National German Scholarship Foundation |
Germany |
2006 – 2008 |
Postdoctoral Fellowship Award |
Deutsche Forschungsgemeinschaft |
Germany |
2008 – 2011 |
Postdoctoral Fellowship Award |
Cancer Research Society |
Canada |
2008 – 2011 |
Postdoctoral Fellowship Award |
Michael Smith Foundation for Health Research |
Canada |
2008 – 2010 |
Postdoctoral Fellowship Award |
Lymphoma Research Foundation |
Canada |
2011 |
Canadian Hematology Society 2011 Research Award |
Junior Faculty |
Canada |
2012 |
Career Investigator Scholar Award |
Michael Smith Foundation for Health Research |
Canada |
2013 |
New Investigator Award |
Canadian Institutes of Health Research |
Canada |
2014 |
Distinguished Achievement Award |
Excellence in Basic Science Research, Faculty of Medicine, University of British Columbia |
Canada |
2014 |
Early Career Excellence in Research and Discovery Award |
Department of Pathology and Laboratory Medicine, University of British Columbia |
Canada |
2017 |
Early Career Award |
Canadian Institutes of Health Research |
Canada |
2018 |
Allen Distinguished Investigator Award |
Paul G. Allen Frontiers Group |
USA |
2020 |
Pathology and Laboratory Medicine Excellence in Research and Discovery Award |
Canada |
2020 |
Distinguished Achievement Award for Excellence in Basic Science Research |
University of British Columbia |
Canada |